Compositions and methods for immune-mediated inflammatory diseases
AssigneeThetis Pharmaceuticals LLC
InventorsGary Mathias, John Parkinson, Aaron Mathias, Frank C. Sciavolino
Life of this patent
Estimating the term…
Abstract
The present invention relates to compositions comprising resolvins and their use in methods of treating immune-mediated inflammatory disease.
Claims28
A method for treating an immune-mediated inflammatory disease in a subject in need of such treatment, the method comprising administering to the subject a pharmaceutical composition comprising a resolvin, or a salt thereof, in a therapeutic regimen of less than once daily, either alone as monotherapy or as adjuvant or neo-adjuvant therapy, optionally in combination with one or more additional therapeutic agents or therapies.
Use of a pharmaceutical composition comprising a resolvin, or a salt thereof, in a method for treating immune-mediated inflammatory disease in a subject, wherein the composition is adapted for administration less than once daily (LTD), optionally wherein the method comprises administering the resolvin, or a salt thereof, in combination with one or more additional therapeutic agents, or one or more additional therapies, such as surgery, radiation therapy, chemotherapy, targeted therapy, biological therapy, non-steroidal anti-inflammatory drugs (NSAIDS), glucocorticoids, disease-modifying antirheumatic drugs (DMARDs), immunosuppressants, aminosalicylates, immunotherapy, hormone therapy, gene therapy, or microbiome therapy.
Dependencies are inferred from the claim text.